Lipogems protagonista nella ricerca riabilitativa in medicina rigenerativa. Un articolo su Eurekalert, fonte autorevolissima sulle novità scientifiche internazionali, riporta gli argomenti della ricerca.
La Fondazione Kessler, non-profit che opera per migliorare la vita delle persone con disabilità fisiche e cognitive (causate da ictus, sclerosi multipla, lesioni cerebrali e del midollo spinale e altre condizioni neurologiche e muscolo-scheletriche croniche) ha ricevuto dei fondi dalla Fondazione Derfner per sostenere la ricerca riabilitativa nell’area della medicina rigenerativa e per formare un erudito gruppo di dottorato per una carriera nella riabilitazione rigenerativa.
Un altro importantissimo riconoscimento per il Lipogems e per il Prof. Carlo Tremolada, che utilizza regolarmente le iniezioni di tessuto adiposo autologo micro-frammentato per trattare patologie alla spalla e alla cuffia dei rotatori. La ricerca della Fondazione Kessler è la prima ad esaminare la sicurezza e l’efficacia delle iniezioni di tessuto adiposo micro frammentato per il dolore cronico alla spalla, in maniera specifica per i pazienti in sedia a rotelle che presentano lesioni del midollo spinale. Per queste persone è facilissimo subire infortuni alla spalla, con conseguente dolore e riduzione della mobilità.
Ma non è tutto: spesso la chirurgia alla spalla rischia di non portare ai risultati sperati ed è per questo che la ricerca mondiale sta studiando delle valide alternative per evitare l’operazione.
Segue l’articolo competo:
Derfner Foundation funds novel research in regenerative medicine at Kessler Foundation
“Derfner Foundation grants support a study of a new intervention for shoulder pain in wheelchair users and the inaugural postdoctoral fellowship in regenerative rehabilitation research”
KESSLER FOUNDATION
Kessler Foundation has received funding from the Derfner Foundation to support applying rehabilitation research to the area of regenerative medicine (“regenerative rehabilitation”). Through the combined gifts, which total $129,000, researchers are investigating a new treatment using micro-fragmented adipose tissue injection for chronic shoulder pain in wheelchair users with spinal cord injury (SCI) and training a doctoral-level scholar for a career in regenerative rehabilitation.
Rotator cuff injuries are a common cause of pain and loss of function among manual wheelchair users with SCI. When pharmacological treatment and physical therapy fail to address the pain, rotator cuff surgery is often the only option. Injection with micro-fragmented adipose tissue is being tested as an alternative when conservative treatments fail. The procedure involves harvesting, processing (using the Lipogems® system), and injection of a sample of the person’s own fat into the shoulder joint under ultrasound guidance. Fat tissue provides cushioning and fills structural defects, and may deposit bioactive and regenerative elements in the damaged tissues. This pilot study is the first to examine the safety and efficacy of the injection of micro-fragmented adipose tissue for chronic shoulder pain in individuals with SCI.
“Because wheelchair users have a high risk for poor outcomes after shoulder surgery, exploration of alternative treatments is extremely important,” explained Trevor Dyson-Hudson, MD, director of SCI Research at Kessler Foundation. “So far, we’ve had six participants undergo the intervention and all have experienced better range of motion and less pain,” he noted. “While results are preliminary, it appears that injection with adipose tissue prepared using the Lipogems system may be effective in treating shoulder pain from rotator cuff injuries in persons with SCI.”
The grant-funded post-doctoral fellow will work under the leadership of Drs. Dyson-Hudson and Gerard Malanga, physiatrist at New Jersey Regenerative Institute and Kessler Institute for Rehabilitation, and a renowned specialist in the nonsurgical treatment of orthopedic and sports-related injuries. “With the Derfner Foundation’s support, we can expand the capacity of Kessler Foundation’s rehabilitation research program to investigate promising regenerative medicine treatments. This new fellowship in regenerative rehabilitation is an important step toward exploring how integrating regenerative medicine with rehabilitation medicine can improve quality of life for people with SCI.”
“The scientists at Kessler Foundation are well equipped to harness the tools of rehabilitation medicine and regenerative medicine for the benefit of people with disabilities,” remarked Jay Lieberman, trustee of the Derfner Foundation. We look forward to following their progress in this new avenue of research.”
Kessler Foundation recently joined the International Consortium for Regenerative Rehabilitation (ICRR). The ICRR is an assemble of leading scientists and clinicians across the domains of regenerative medicine and rehabilitation science that facilitate the creation and transfer of knowledge associated with the development and translation of technologies that restore function and enhance the quality of life of patients. Drs. Dyson-Hudson and Malanga serve as delegates on the ICRR Leadership Council.
###
About Kessler Foundation
Kessler Foundation, a major nonprofit organization in the field of disability, is a global leader in rehabilitation research that seeks to improve cognition, mobility and long-term outcomes, including employment, for people with neurological disabilities caused by diseases and injuries of the brain and spinal cord. Kessler Foundation leads the nation in funding innovative programs that expand opportunities for employment for people with disabilities. Learn more by visiting http://www.
Articolo completo sul sito eurekalert.org
Potrebbe interessarti anche:
Lipogems: la spalla di Edoardo Stoppa torna nuova
